Analysis of The Budget Impact of Secukinumab use Versus Anti-Tnf Agents in Ankylosing Spondylitis Patients

OBJECTIVES: To conduct an analysis of the budget impact of secukinumab use in the treatment of Ankylosing Spondylitis in Colombia versus TNF-α inhibitors. METHODS: A budget impact model was developed to compare the drug acquisition and administration costs with and without the introduction of secuki...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Value in health 2017-10, Vol.20 (9), p.A937
Hauptverfasser:	Romero Prada, ME, Roa Cardenas, NC, Serrano, GY, Huerfano, LM
Format:	Artikel
Sprache:	eng
Schlagworte:	Analysis Ankylosing spondylitis Capitation Cost analysis First year Health care expenditures Market shares Marketing Medical treatment Monoclonal antibodies Natural history Patients Projections Rheumatic diseases Savings Spondylitis Tumor necrosis factor-TNF Tumor necrosis factor-α
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!